Early research (Phase 1)Looking for participantsNCT06349837
What this trial is testing
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Who this might be right for
Solid Tumor
Sichuan University 24